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ABSTRACT
The authors report a case of disseminated cutaneous leishmaniasis caused by Leishmania 
(Viannia) braziliensis, in a 55 years old patient with 1,119 lesions distributed throughout the 
body. The patient resides in Sabáudia municipality, North of Paraná State, Southern Brazil, 
where there was no previous report of this form of leishmaniasis. Treatment with meglumine 
antimoniate was successful, although the diagnosis was made only five months later.
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INTRODUCTION
Leishmaniases are infectious diseases caused by protozoa of the genus 
Leishmania, with a wide spectrum of clinical manifestations, depending on the 
species of Leishmania involved1. Originally, leishmaniases were considered wild 
zoonoses, but have been reported in rural and urban areas where domestic animals, 
especially dogs, have been often diagnosed with Leishmania infection2. 
Disseminated cutaneous leishmaniasis (DL) caused by Leishmania (Viannia) 
braziliensis and Leishmania (Leishmania) amazonensis is a rare form of clinical 
manifestation and accounts for approximately 2% of the reported cases of cutaneous 
leishmaniasis (CL) in Brazil2. Torres3 reported the first case of DL caused by L. 
(V.) braziliensis in the State of Bahia, Brazil. In 1986, Costa et al.4 published the 
first case of CL. Since then, just a few cases5 of DL, with additional research on the 
parasites characteristics, their immunological behavior and response of patients to 
treatment2,5 have been reported. DL is characterized by expressing multiple papular 
acneiform lesions, compromising exposed areas, such as limbs, and frequently face 
and trunk2,4,5. The number of lesions can reach hundreds, according to the Ministry 
of Health2. 
Another atypical form of CL, known as difuse cutaneous leishmaniasis (DCL) 
or anergic-DCL, caused by L. (L.) amazonensis2, was first reported by Silva6, 
in Brazil, and Convit7, in Venezuela. DCL is characterized by the presence of 
multiple non-ulcerated nodular lesions, weak response of T-cells to antigens of 
Leishmania parasites (amastigotes) and a large number of Leishmania inside 
macrophages8. DCL is also rare, with 1 or 2 cases diagnosed per year and the 
number of lesions can, as well, reach the hundreds2,8. These two clinical forms, 
DL and DCL, were precisely compared and differentiated based on reported cases 
by Hashiguchi et al.9.
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This report deals with a case of DL in an inhabitant 
of Vila dos Crentes, a rural town in the municipality of 
Sabáudia, North of Paraná State, Southern Brazil, showing 
an extraordinary number of cutaneous lesions. 
CASE REPORT
At the beginning of March 2015, the patient, a 55 years 
old driver, observed a lesion on the anterior surface of 
his leg, with a granular bottom and raised edges. After 
approximately three months of development of the primary 
lesion, small lesions appeared on the face and thereafter 
throughout the body (scalp, all the face, neck, arms, 
hands, including the palms, legs and the dorsal part of 
the foot), except in the palms surface and genital organ, 
totaling 1,119 lesions, counted with the a manual counter 
(Hand Held). The disease was identified five months after 
the onset. During this period, the patient had lost about 
15 kg. When the first lesion appeared, the patient initially 
received an unsuccessful treatment for allergy. Thereafter, 
he was treated with six ampoules of penicillin G benzathine 
1,200,000 IU, and had unsuccessful results once again. It 
is noteworthy that the municipality of Sabaúdia is located 
in the important center of Ivai-Pirapó from the circuit 
Paraná-Paranapanema of CL incidence, in the North-
Central mesoregion of Paraná State10. 
Evolution of the case and laboratory examination
The patient fail to respond to treatment within three 
months of the disease onset, then he sought medical 
resources in the municipality of Arapongas, Paraná, where 
he was subjected to the following tests: V.D.R.L., negative; 
FTA-Abs IgG and IgM, negative; Herpes simplex Virus 
anti-IgG, positive (23.8 U/mL); Herpes simplex Virus anti-
IgM, negative; Rubella anti-IgG, positive (73.7 IU/mL); 
Rubella anti-IgM, negative; Aspartate Aminotransferase 
(AST), normal; Alanine Aminotransferase (ALT), normal; 
Lactic dehydrogenase (LDH), normal; Gamma Glutamyl 
Transferase, normal; Alpha 1-Acid Glycoprotein, increased 
164 mg/dL; Hepatitis B, negative; Hepatitis C, negative; 
Brucella anti-IgG and IgM, negative; Chlamydia trachomatis 
anti-IgG, reagent (1/80); Chlamydia trachomatis anti-IgM, 
negative; Complete blood count, normal; Anti-HIV, negative. 
The biopsy, performed in a private laboratory, showed 
the absence of viral infection, a favorable morphologic 
pattern in the diagnosis of a staphylococci and screening 
for fungi negative. The indirect immunofluorescence 
test (IIF) for Leishmania, held in another laboratory 
was negative. This examination was performed with a 
kit containing L. (L.) infantum, for diagnosis of visceral 
Figure 1 - Patient with disseminated leishmaniasis. (A) 
Disseminated lesions before treatment; (B) After treatment 
with 60 ampoules of Glucantime®; (C) After treatment with 120 
ampoules of Glucantime®
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leishmaniasis. Finally, after 5 months, the patient was 
sent to an infectious disease specialist of the Laboratory 
of Medical Entomology from the city of Arapongas, and 
amastigote forms of Leishmania were detected via direct 
search (DS) of material collected from the primary lesion 
of the right leg and three other lesions (face, abdomen, 
and back). Lesion aspirates were mixed with a saline 
solution containing penicillin G potassium (Sigma) 
(25,000 IU/mL), and streptomycin (Sigma) (2 mg/mL), 
at 4 ºC for 24 h; later they were incubated in 199 medium, 
containing 10% of inactivated fetal bovine serum at 25 °C 
and the presence of the parasite was detected after five 
days. It was isolated in the Laboratory of Leishmaniasis 
from Universidade Estadual de Maringá (UEM) and was 
sent to Coleção de Leishmania do Instituto Oswaldo Cruz 
(CLIOC), Rio de Janeiro, Brazil, for identification. The 
parasite was identified as L. (V.) braziliensis (IOC-L 3636).
After the diagnosis, the patient was treated with 
intravenous Glucantime® (Sanofi-Aventis Farmacêutica 
Ltda.), 20 mg/kg /day for 20 days (August 7, 2015, to 
August 26, 2015). The patient showed a great improvement, 
with partial healing of lesions, requiring more 20 days 
of treatment (August 27, 2015, to September 9, 2015), 
according to the above described procedure. In total, 
120 ampoules of glucantime were used. The patient was 
discharged and showed clinical cure one month after the 
end of treatment. 
DISCUSSION
The extraordinary number of 1,119 lesions observed 
in the patient is the most important fact in this case. The 
parasite was identified in the CLIOC as L. (V.) braziliensis, 
confirming that most of the DL cases described in Brazil 
are associated with this species of Leishmania4,11. In Paraná 
State, the occurrence of human and canine-CL cases is 
mainly attributed to infection by L. (V.) braziliensis12. 
The current case draws attention to the number of 
lesions compared to other cases described in Brazil and in 
the Southern region, given that the cases of CL have been 
reported almost exclusively in the North and Northeast of 
Brazil4,5,11. In Maranhão State, Galvão et al.5 reported a 
patient with 58 lesions; Carvalho et al.8, in the State of Bahia, 
found in eight patients, a number of lesions ranging from 75 
to 800. Turetz et al.11, also in Bahia, described 42 cases of 
DL, with the number of lesions ranging from 10 to 300. They 
drew attention to the increase in the number of patients with 
DL, classifying it as an emerging form of leishmaniasis, with 
distinct clinical forms, associated with agricultural activities 
and the immune response of the host11,13. Nevertheless, there 
is evidence that isolates of L. (V.) braziliensis- from DL 
patients differ genotypically from the ones isolated from 
patients with cutaneous and mucosal leishmaniasis14,15, and 
DL isolates also induce higher inflammatory responses than 
isolates from CL patients16. 
The dissemination of the lesions in the studied patient 
occurred in the third month, starting from the beginning 
of the first lesion. However, there was no impairment of 
mucous tissue. DL presents numerous acneiform, papular 
and ulcerated lesions that may arise abruptly, suggesting the 
hematogenous or lymphatic dissemination of the parasite11. 
Usually, the finding of amastigote forms of Leishmania on 
DS for the diagnosis of DL is low2,13, but in this case, the 
number of amastigote forms of Leishmania detected on DS 
was abundant, although the disease had appeared 150 days 
before being confirmed. The patient’s weight loss (15 kg) 
is not something new, given that fever, general malaise, 
muscle pain and especially weight loss-are reported among 
the various systemic manifestations of DL2,5,11.
Despite biopsy and IIF negative results, the abundant 
amastigote forms found in the sample collected from lesions 
and the rapid development in culture medium were decisive 
factors for the fast and accurate diagnosis of the current 
DL case. Treatment with meglumine antimoniate was 
successful, and the response to the medication was quick, 
given that the patient had the DL diagnosis after five months 
from the onset of the first lesion. It is noteworthy that the 
patient did not exhibit any signs of recurrence of -disease 
until June 2016, nine months after the end of the treatment. 
In addition to the extraordinary number of cutaneous 
lesions, which motivated this case report, the difficult 
path search for treatment by the patient, who lived in an 
important endemic area of TL should be pointed. It shows 
clearly the lack of preparation of the staff working in the 
Brazilian health system, mainly concerning vector-borne 
diseases like leishmaniasis. 
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